Stocks and Investing Stocks and Investing
Wed, November 25, 2020

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $203 on, Nov 25th, 2020


Published on 2024-10-27 14:52:26 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $200 to $203 on, Nov 25th, 2020.

David has made no other calls on ALNY in the last 4 months.



There are 2 other peers that have a rating on ALNY. Out of the 2 peers that are also analyzing ALNY, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold and Decreased Target to $156 on, Tuesday, August 11th, 2020


This is the rating of the analyst that currently disagrees with David


  • Joel Beatty of "Citigroup" Initiated at Strong Buy and Held Target at $170 on, Tuesday, September 8th, 2020
Contributing Sources